Forget Anthropic: Biotech Is Quietly Dominating the IPO Sphere

As investors wait for the Claude developer to file its official IPO paperwork, several biotechs are going public and doing just fine.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。